Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Wenting

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Journal of the American College of Cardiology|December 1, 1987
Effect of a single oral dose of milrinone on left ventricular diastolic performance in the failing human heartF Piscione, B E Jaski, G J Wenting, et al.
Clinics in Endocrinology and Metabolism|November 1, 1981
Pathogenesis of mineralocorticoid hypertensionM A Schalekamp, G J Wenting, A J Man in 't Veld
British Medical Journal|November 3, 1979
Does captopril lower blood pressure in anephric patients?A J Man in 't Veld, G J Wenting, M A Schalekamp
Clinical Science (London, England : 1979)|June 1, 1992
Effects of cyclosporin A on glomerular barrier function in the nephrotic syndromeR Zietse, G J Wenting, P Kramer, et al.
Transplantation Proceedings|June 1, 1988
Fractional excretion of protein: a marker of the efficacy of cyclosporine A treatment in nephrotic syndromeR Zietse, G J Wenting, P Kramer, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Time-course of vascular resistance changes in mineralocorticoid hypertension of manG J Wenting, A J Man in 't Veld, M A Schalekamp
Transplant International : Official Journal of the European Society for Organ Transplantation|December 1, 1988
Mononuclear cells infiltrating kidney allografts in the absence of rejection. Effect of conversion from cyclosporin to azathioprine therapyD J Versluis, F J ten Kate, G J Wenting, et al.
Transplantation Proceedings|February 1, 1989
Phenotypic analysis of interstitial infiltrates in kidney allograft biopsies after one year of cyclosporine therapyD J Versluis, F J ten Kate, G J Wenting, et al.
Transplantation Proceedings|February 1, 1987
Dihydroergotoxine (hydergine) to prevent cyclosporine nephrotoxicity in kidney transplant recipientsH H Vincent, G J Wenting, J Jeekel, et al.
Transplantation Proceedings|October 1, 1987
Impaired fractional excretion of lithium: a very early marker of cyclosporine nephrotoxicityH H Vincent, G J Wenting, M A Schalekamp, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Journal of the American College of Cardiology|December 1, 1987
Effect of a single oral dose of milrinone on left ventricular diastolic performance in the failing human heartF Piscione, B E Jaski, G J Wenting, et al.
Clinics in Endocrinology and Metabolism|November 1, 1981
Pathogenesis of mineralocorticoid hypertensionM A Schalekamp, G J Wenting, A J Man in 't Veld
British Medical Journal|November 3, 1979
Does captopril lower blood pressure in anephric patients?A J Man in 't Veld, G J Wenting, M A Schalekamp
Clinical Science (London, England : 1979)|June 1, 1992
Effects of cyclosporin A on glomerular barrier function in the nephrotic syndromeR Zietse, G J Wenting, P Kramer, et al.
Transplantation Proceedings|June 1, 1988
Fractional excretion of protein: a marker of the efficacy of cyclosporine A treatment in nephrotic syndromeR Zietse, G J Wenting, P Kramer, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Time-course of vascular resistance changes in mineralocorticoid hypertension of manG J Wenting, A J Man in 't Veld, M A Schalekamp
Transplant International : Official Journal of the European Society for Organ Transplantation|December 1, 1988
Mononuclear cells infiltrating kidney allografts in the absence of rejection. Effect of conversion from cyclosporin to azathioprine therapyD J Versluis, F J ten Kate, G J Wenting, et al.
Transplantation Proceedings|February 1, 1989
Phenotypic analysis of interstitial infiltrates in kidney allograft biopsies after one year of cyclosporine therapyD J Versluis, F J ten Kate, G J Wenting, et al.
Transplantation Proceedings|February 1, 1987
Dihydroergotoxine (hydergine) to prevent cyclosporine nephrotoxicity in kidney transplant recipientsH H Vincent, G J Wenting, J Jeekel, et al.
Transplantation Proceedings|October 1, 1987
Impaired fractional excretion of lithium: a very early marker of cyclosporine nephrotoxicityH H Vincent, G J Wenting, M A Schalekamp, et al.
Pageof 8